Endpoint definition
↥Filter registries None
Check pre-conditions None
Include endpoints
Check conditions None
Apply sex-specific rule None
Extra metadata
Filter registries None
Check pre-conditions None
Include endpoints
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Inflammatory bowel disease treatment related agents based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
All | Female | Male | |
---|---|---|---|
Number of individuals | 41038 | 24595 | 16443 |
Unadjusted prevalence (%) | 15.78 | 16.74 | 14.54 |
Mean age at first event (years) | 51.60 | 49.44 | 54.83 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.03 | 2.45 [2.19, 2.74] | 3.1e-54 | 3923 |
15 years | 0.02 | 2.80 [2.54, 3.08] | 1.0e-98 | 3272 |
5 years | 0.00 | 4.04 [3.68, 4.45] | <1e-100 | 1377 |
1 year | 0.00 | 4.29 [3.63, 5.07] | 1.2e-64 | 288 |
Index endpoint: IBD_DRUGS – Inflammatory bowel disease treatment related agents
GWS hits:
before Inflammatory bowel disease treatment related agents
after Inflammatory bowel disease treatment related agents
Loading survival analyses plot
Loading survival analyses table